Andrew Huberman Peptides: The Private-Clinic Pathway They Likely Used
A clinical and journalistic breakdown of the peptide protocols Andrew Huberman has discussed publicly, the private-clinic process behind them, and what the peer-reviewed evidence actually says about BPC-157, TB-500, CJC-1295, and more.